Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

471
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
471
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

574
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
574
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

428
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
428
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

460
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
460
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

262
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
262
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

244
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
244

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stricturing Diseases of the Gastrointestinal Tract-Current Clinical Practice.

JGH open : an open access journal of gastroenterology and hepatology·2026
Same author

The Predilection of Specific Diseases to Affect Different Sections of the Esophagus.

Life (Basel, Switzerland)·2025
Same author

Gastrointestinal Fistulas-What Gastroenterologists Need to Know in 2025.

Canadian journal of gastroenterology & hepatology·2025
Same author

A clinician's perspective on the new organ mesentery and non-vascular mesenteropathies.

Frontiers in physiology·2024
Same author

Intestinal Parasitic Infections in 2023.

Gastroenterology research·2023
Same author

Radiation in Gastroenterology.

Gastroenterology research·2023

Related Experiment Video

Updated: Oct 22, 2025

Multimodality Diagnosis of Mesenteric Ischemia
05:07

Multimodality Diagnosis of Mesenteric Ischemia

Published on: July 21, 2023

821

Ischemic bowel disease in 2021.

Monjur Ahmed1

  • 1Department of Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University, Philadelphia, PA 19107, United States. monjur.ahmed@jefferson.edu.

World Journal of Gastroenterology
|August 27, 2021
PubMed
Summary

Ischemic bowel disease (ISBODI), encompassing colon ischemia, acute mesenteric ischemia (AMI), and chronic mesenteric ischemia (CMI), presents with abdominal pain. Diagnosis relies on clinical suspicion, imaging, and colonoscopy, with treatment ranging from conservative care to surgical or endovascular interventions.

Keywords:
Acute mesenteric ischemiaChronic mesenteric ischemiaColon ischemiaEndovascular treatment of acute and chronic mesenteric ischemiaIschemic colitis

More Related Videos

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
05:08

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

Published on: March 1, 2022

4.1K
Murine Ileocolic Bowel Resection with Primary Anastomosis
08:49

Murine Ileocolic Bowel Resection with Primary Anastomosis

Published on: October 29, 2014

16.7K

Related Experiment Videos

Last Updated: Oct 22, 2025

Multimodality Diagnosis of Mesenteric Ischemia
05:07

Multimodality Diagnosis of Mesenteric Ischemia

Published on: July 21, 2023

821
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
05:08

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

Published on: March 1, 2022

4.1K
Murine Ileocolic Bowel Resection with Primary Anastomosis
08:49

Murine Ileocolic Bowel Resection with Primary Anastomosis

Published on: October 29, 2014

16.7K

Area of Science:

  • Gastroenterology
  • Vascular Surgery
  • Abdominal Imaging

Background:

  • Ischemic bowel disease (ISBODI) comprises colon ischemia, acute mesenteric ischemia (AMI), and chronic mesenteric ischemia (CMI).
  • Colon ischemia is the most prevalent form, followed by AMI and CMI.
  • Multiple risk factors contribute to the development of ISBODI.

Purpose of the Study:

  • To summarize the epidemiology, clinical presentation, diagnostic modalities, and management strategies for ischemic bowel disease.
  • To highlight the importance of early diagnosis and multidisciplinary management.
  • To discuss the evolving treatment landscape, including endovascular options.

Main Methods:

  • Review of epidemiological data and clinical presentations of ISBODI subtypes.
  • Analysis of diagnostic tools including imaging studies and colonoscopy with biopsy.
  • Evaluation of treatment outcomes for conservative, surgical, and endovascular approaches.

Main Results:

  • Abdominal pain is the hallmark symptom across all ISBODI types.
  • Diagnostic workup typically involves imaging and colonoscopy with biopsy.
  • Treatment strategies are diverse, including conservative management, open surgery with revascularization, and percutaneous endovascular procedures.

Conclusions:

  • Prompt clinical suspicion is crucial for timely diagnosis and management of ISBODI.
  • A multidisciplinary team approach is essential for optimal patient outcomes.
  • Percutaneous endovascular treatment is gaining traction as a viable alternative to open surgery for ISBODI.